| Literature DB >> 33876337 |
Ilonka N de Keijzer1, Marieke Poterman2, Anthony R Absalom2, Jaap Jan Vos2, Massimo A Mariani3, Thomas W L Scheeren2.
Abstract
Patients undergoing coronary artery bypass grafting (CABG) are at risk of developing postoperative renal impairment, amongst others caused by renal ischemia and hypoxia. Intra-operative monitoring of renal region tissue oxygenation (SrtO2) might be a useful tool to detect renal hypoxia and predict postoperative renal impairment. Therefore, the aim of this study was to assess the ability of intra-operative SrtO2 to predict postoperative renal impairment, defined as an increase of serum creatinine concentrations of > 10% from individual baseline, and compare this with the predictive abilities of peripheral and cerebral tissue oxygenation (SptO2 and SctO2, respectively) and renal specific tissue deoxygenation. Forty-one patients undergoing elective CABG were included. Near-infrared spectroscopy (NIRS) was used to measure renal region, peripheral (thenar muscle) and cerebral tissue oxygenation during surgery. Renal region specific tissue deoxygenation was defined as a proportionally larger decrease in SrtO2 than SptO2. ROC analyses were used to compare predictive abilities. We did not observe an association between tissue oxygenation measured in the renal region and cerebral oxygenation and postoperative renal impairment in this small retrospective study. In contrast, SptO2 decrease > 10% from baseline was a reasonable predictor with an AUROC of 0.767 (95%CI 0.619 to 0.14; p = 0.010). Tissue oxygenation of the renal region, although non-invasively and continuously available, cannot be used in adults to predict postoperative renal impairment after CABG. Instead, peripheral tissue deoxygenation was able to predict postoperative renal impairment, suggesting that SptO2 provides a better indication of 'general' tissue oxygenation status.Registered at ClinicalTrials.gov: NCT01347827, first submitted April 27, 2011.Entities:
Keywords: Acute kidney injury; Cerebral oxygenation; Coronary artery bypass grafting (CABG); Postoperative renal impairment; Renal oxygenation
Mesh:
Year: 2021 PMID: 33876337 PMCID: PMC9162967 DOI: 10.1007/s10877-021-00701-4
Source DB: PubMed Journal: J Clin Monit Comput ISSN: 1387-1307 Impact factor: 1.977
Fig. 1Example of the calculation of renal region specific tissue deoxygenation. The grey area is the area under the threshold (AUT; (%min)) of renal region specific tissue deoxygenation, which was calculated by subtracting the SrtO2 in % from baseline (renal tissue (blue line)) from the SptO2 in % from baseline (peripheral tissue (orange line))
Demographic, intra-operative and postoperative characteristics in patients undergoing on-pump or off-pump CABG, compared by postoperative renal function. Variables are number (%), mean (SD) or median [IQR]
| All patients ( | Patients without renal impairment (n = 30) | Patients with renal impairment (n = 11) | P value | |
|---|---|---|---|---|
| Gender; male | 38 (93%) | 27 (90%) | 11 (100%) | 0.551 |
| Age; years | 63 (9) | 62 (9) | 66 (9) | 0.155 |
| BMI; kg m−2 | 27.6 (3.4) | 27.3 (3.2) | 28.4 (4.0) | 0.361 |
| Operated on CPB (on-pump) | 19 (46%) | 12 (40%) | 7 (64%) | 0.290 |
| EuroSCORE | 1.8 [1.3–3.0]1 | 1.5 [1.0–2.9] | 2.6 [1.6–3.3] | 0.095 |
| DM type II | 10 (24%) | 8 (27%) | 2 (18%) | 0.700 |
| Hypertension | 11 (27%) | 7 (23%) | 7 (64%) | 0.445 |
| Smoking | 26 (63%)2 | 19 (63%) | 7 (64%) | 1.000 |
| Pre-operative LVEF | 0.349 | |||
| 55–70% | 19 (46%) | 16 (53%) | 3 (27%) | |
| 40–55% | 19 (46%) | 12 (40%) | 7 (64%) | |
| < 40% | 3 (7%) | 2 (7%) | 1 (9%) | |
| Preoperative Creatinine; µmol l−1 | 84 [75–103] | 84 [76–94] | 93 (28) | 0.942 |
| Baseline Hb; mmol l−1 | 8.3 (0.7) | 8.4 [8.2–8.6] | 8.2 (0.9) | 0.851 |
| Duration of surgery; min | 180 [159–196] | 173 (26) | 197 [182–240] | 0.008* |
| CPB timea; min | 83 (22) | 82 (20) | 86 (26) | 0.697 |
| Aorta cross clamp timea; min | 53 (14) | 53 (13) | 53 (15) | 0.997 |
| No. of grafts per patient | 3 [3, 4] | 3 [3–3] | 4 [3, 4] | 0.009* |
| Intra-operative analyses | ||||
| Lactate; highest | 2.4 (0.9) | 2.4 (0.8) | 2.5 (1.1) | 0.883 |
| Mean intraoperative MAP; mmHg | 70 (6) | 70 (6) | 71 (7) | 0.574 |
| Stay on ICU; days | 1 [1–1] | 1 [1–1] | 1 [1–4] | 0.315 |
| Stay in hospital; days | 8 [6–11] | 8 (3) | 11 (5) | 0.052 |
1EuroSCORE is missing from 2 patients. 2Smoking is missing from 1 patient
aOnly in on-pump patients. BMI body mass index, CPB cardiopulmonary bypass, ASA american society of anesthesiologist status, EuroSCORE European system for cardiac operative risk evaluation, DM type II diabetes mellitus type 2, LVEF left ventricular ejection fraction, Hb haemoglobin, MAP mean arterial pressure, ICU intensive care unit. Significance is indicated with * for p < 0.05
Intra-operative oxygenation data of patients with and without postoperative renal impairment. Variables are mean (SD) or median [IQR]
| No renal impairment (n = 30) | Renal impairment (n = 11) | P value | |
|---|---|---|---|
| SrtO2 | |||
| Baseline; % | 80 [75–86] | 77 (11) | 0.571 |
| AUT absolute decrease SrtO2; %min | |||
| Below 90% SrtO2 | 2396 [1372–3347] | 4333 (3539) | 0.359 |
| Below 80% SrtO2 | 779 [204–1408] | 876 [115–5348] | 0.407 |
| Below 70% SrtO2 | 114 [12–275] | 172 [54–1880] | 0.287 |
| Below 60% SrtO2 | 13 [0–53] | 34 [0–285] | 0.226 |
| AUT relative decrease SrtO2; %min | |||
| > 5% from baseline | 319 [131–701] | 297 [207–895] | 0.717 |
| > 10% from baseline | 119 [29–358] | 119 [63–502] | 0.805 |
| > 15% from baseline | 46 [10–157] | 54 [20–312] | 0.761 |
| AUT of renal region specific tissue deoxygenation; %min | 720 [143–1293] | 443 [116–1507] | 0.532 |
| SctO2 | |||
| Baseline; % | 65 (10) | 63 (10) | 0.547 |
| AUT absolute decrease SctO2; %min | |||
| Below 90% SctO2 | 5984 (2219) | 7697 (2020) | 0.051 |
| Below 80% SctO2 | 3710 (2066) | 4989 (2491) | 0.105 |
| Below 70% SctO2 | 1092 [445–3253] | 2520 (1938) | 0.391 |
| Below 60% SctO2 | 146 [16–996] | 593 [109–1609] | 0.315 |
| AUT relative decrease SctO2; %min | |||
| > 5% from baseline | 177 [60–576] | 289 [158–711] | 0.571 |
| > 10% from baseline | 57 [13–255] | 147 [41–287] | 0.391 |
| > 15% from baseline | 21 [3–90] | 67 [9–92] | 0.375 |
| SptO2 | |||
| Baseline; % | 84 (7) | 83 (6) | 0.710 |
| AUT 10% below baseline; %min | 36 [0–313] | 215 [72–934] | 0.009* |
SrtO renal region tissue oxygenation, SctO cerebral tissue oxygenation, SptO peripheral tissue oxygenation, AUT area under the threshold. Significance is indicated with * for p < 0.05
Intra-operative oxygenation data of patients who underwent on-pump or off-pump CABG. Variables are mean (SD) or median [IQR]
| Off-pump (n = 22) | On-pump (n = 19) | P value | |
|---|---|---|---|
| SrtO2 | |||
| Baseline; % | 78 (10) | 81 (9) | 0.312 |
| AUT absolute decrease SrtO2; %min | |||
| Below 90% SrtO2 | 2218 [1302 – 3959] | 2591 [1922–3583] | 0.480 |
| Below 80% SrtO2 | 752 [125–1700] | 802 [389–1591] | 0.433 |
| Below 70% SrtO2 | 119 [8–348] | 121 [51–301] | 0.695 |
| Below 60% SrtO2 | 19 [0–100] | 10 [0–41] | 0.463 |
| AUT relative decrease SrtO2; %min | |||
| > 5% from baseline | 276 [74–500] | 452 [238–911] | 0.089 |
| > 10% from baseline | 107 [14–213] | 166 [67–502] | 0.182 |
| > 15% from baseline | 28 [10–123] | 77 [13–267] | 0.306 |
| AUT of renal region specific tissue deoxygenation; %min | 327 [81–1044] | 1015 [443–1784] | 0.025* |
| SctO2 | |||
| Baseline; % | 65 (8) | 63 (12) | 0.612 |
| AUT absolute decrease SctO2; %min | |||
| Below 90% SctO2 | 6273 (2524) | 6641 (2545) | 0.645 |
| Below 80% SctO2 | 3940 (2154) | 4184 (2367) | 0.733 |
| Below 70% SctO2 | 1227 [666–3261] | 1777 [420–3891] | 0.948 |
| Below 60% SctO2 | 159 [52–996] | 193 [12–1609] | 0.923 |
| AUT relative decrease SctO2; %min | |||
| > 5% from baseline | 191 [86–537] | 230 [44–652] | 0.907 |
| > 10% from baseline | 57 [17- 268] | 127 [14–272] | 0.826 |
| > 15% from baseline | 25 [3- 118] | 49 [5–83] | 0.995 |
| SptO2 | |||
| Baseline; % | 85 (5) | 82 (8) | 0.180 |
| AUT 10% below baseline; %min | 69 [1–363] | 68 [5–498] | 0.854 |
SrtO renal region tissue oxygenation, SctO cerebral tissue oxygenation, SptO peripheral tissue oxygenation, AUT area under the threshold. Significance is indicated with * for p < 0.05
Results of ROC analyses
| AUROC | 95% CI | P value | |
|---|---|---|---|
| SrtO2 | |||
| Baseline, % | 0.439 | 0.225 to 0.653 | 0.556 |
| AUT 90% | 0.597 | 0.366 to 0.828 | 0.346 |
| AUT 80% | 0.588 | 0.363 to 0.813 | 0.393 |
| AUT 70% | 0.612 | 0.407 to 0.817 | 0.276 |
| AUT 60% | 0.626 | 0.415 to 0.837 | 0.222 |
| AUT > 5% from baseline | 0.539 | 0.341 to 0.737 | 0.702 |
| AUT > 10% from baseline | 0.527 | 0.323 to 0.731 | 0.791 |
| AUT > 15% from baseline | 0.533 | 0.327 to 0.739 | 0.746 |
| Renal region specific tissue deoxygenation | |||
| AUT of renal specific tissue deoxygenation | 0.433 | 0.232 to 0.634 | 0.517 |
| SctO2 | |||
| Baseline, % | 0.453 | 0.257 to 0.649 | 0.648 |
| AUT 90% | 0.676 | 0.472 to 0.880 | 0.088 |
| AUT 80% | 0.648 | 0.448 to 0.849 | 0.149 |
| AUT 70% | 0.591 | 0.381 to 0.801 | 0.377 |
| AUT 60% | 0.605 | 0.406 to 0.804 | 0.310 |
| AUT > 5% from baseline | 0.561 | 0.354 to 0.767 | 0.556 |
| AUT > 10% from baseline | 0.591 | 0.391 to 0.791 | 0.377 |
| AUT > 15% from baseline | 0.592 | 0.399 to 0.786 | 0.369 |
| SptO2 | |||
| Baseline, % | 0.442 | 0.257 to 0.628 | 0.576 |
| AUT > 10% from baseline | 0.767 | 0.619 to 0.914 | 0.010* |
| Preoperative serum creatinine, μmol l−1 | 0.508 | 0.334 to 0.864 | 0.941 |
SrtO renal region tissue oxygenation, SctO cerebral tissue oxygenation, SptO peripheral tissue oxygenation, AUT area under the threshold. Significance is indicated with * for p < 0.05